References
1. Kuo P, Chen MM, Decker RH, Yarbrough WG, Judson BL. Hypopharyngeal
cancer incidence, treatment, and survival: temporal trends in the United
States. The Laryngoscope. 2014;124(9):2064-9.
2. Cooper JS, Porter K, Mallin K, Hoffman HT, Weber RS, Ang KK, et al.
National Cancer Database report on cancer of the head and neck: 10-year
update. Head & neck. 2009;31(6):748-58.
3. Hall SF, Groome PA, Irish J, O’Sullivan B. The natural history of
patients with squamous cell carcinoma of the hypopharynx. The
Laryngoscope. 2008;118(8):1362-71.
4. Chung EJ, Lee SH, Baek SH, Park IS, Cho SJ, Rho YS. Pattern of
cervical lymph node metastasis in medial wall pyriform sinus carcinoma.
The Laryngoscope. 2014;124(4):882-7.
5. Lefebvre JL, Andry G, Chevalier D, Luboinski B, Collette L, Traissac
L, et al. Laryngeal preservation with induction chemotherapy for
hypopharyngeal squamous cell carcinoma: 10-year results of EORTC trial
24891. Annals of oncology : official journal of the European Society for
Medical Oncology. 2012;23(10):2708-14.
6. Newman JR, Connolly TM, Illing EA, Kilgore ML, Locher JL, Carroll WR.
Survival trends in hypopharyngeal cancer: a population-based review. The
Laryngoscope. 2015;125(3):624-9.
7. Perry A, Casey E, Cotton S. Quality of life after total laryngectomy:
functioning, psychological well-being and self-efficacy. International
journal of language & communication disorders. 2015;50(4):467-75.
8. Wolf GT, Fisher SG, Hong WK, Hillman R, Spaulding M, Laramore GE, et
al. Induction chemotherapy plus radiation compared with surgery plus
radiation in patients with advanced laryngeal cancer. The New England
journal of medicine. 1991;324(24):1685-90.
9. Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L,
Sahmoud T. Larynx preservation in pyriform sinus cancer: preliminary
results of a European Organization for Research and Treatment of Cancer
phase III trial. EORTC Head and Neck Cancer Cooperative Group. Journal
of the National Cancer Institute. 1996;88(13):890-9.
10. Lefebvre JL, Rolland F, Tesselaar M, Bardet E, Leemans CR, Geoffrois
L, et al. Phase 3 randomized trial on larynx preservation comparing
sequential vs alternating chemotherapy and radiotherapy. Journal of the
National Cancer Institute. 2009;101(3):142-52.
11. Lefebvre JL, Pointreau Y, Rolland F, Alfonsi M, Baudoux A, Sire C,
et al. Induction chemotherapy followed by either chemoradiotherapy or
bioradiotherapy for larynx preservation: the TREMPLIN randomized phase
II study. Journal of clinical oncology : official journal of the
American Society of Clinical Oncology. 2013;31(7):853-9.
12. Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, et
al. Concurrent chemotherapy and radiotherapy for organ preservation in
advanced laryngeal cancer. The New England journal of medicine.
2003;349(22):2091-8.
13. National Comprehensive Cancer Network In: (NCCN) Clinical Practice
Guidelines in Oncology. Head and neck Cancer, Version 1. 2020.
[Available from:
https://www.nccn.org/professionals/physician_gls/default.aspx.
14. Prades JM, Lallemant B, Garrel R, Reyt E, Righini C, Schmitt T, et
al. Randomized phase III trial comparing induction chemotherapy followed
by radiotherapy to concomitant chemoradiotherapy for laryngeal
preservation in T3M0 pyriform sinus carcinoma. Acta oto-laryngologica.
2010;130(1):150-5.
15. Pointreau Y, Garaud P, Chapet S, Sire C, Tuchais C, Tortochaux J, et
al. Randomized trial of induction chemotherapy with cisplatin and
5-fluorouracil with or without docetaxel for larynx preservation.
Journal of the National Cancer Institute. 2009;101(7):498-506.
16. Haddad R, O’Neill A, Rabinowits G, Tishler R, Khuri F, Adkins D, et
al. Induction chemotherapy followed by concurrent chemoradiotherapy
(sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone
in locally advanced head and neck cancer (PARADIGM): a randomised phase
3 trial. The Lancet Oncology. 2013;14(3):257-64.
17. Hitt R, Grau JJ, López-Pousa A, Berrocal A, García-Girón C, Irigoyen
A, et al. A randomized phase III trial comparing induction chemotherapy
followed by chemoradiotherapy versus chemoradiotherapy alone as
treatment of unresectable head and neck cancer. Annals of oncology :
official journal of the European Society for Medical Oncology.
2014;25(1):216-25.
18. Chen YP, Guo R, Liu N, Liu X, Mao YP, Tang LL, et al. Efficacy of
the Additional Neoadjuvant Chemotherapy to Concurrent Chemoradiotherapy
for Patients with Locoregionally Advanced Nasopharyngeal Carcinoma: a
Bayesian Network Meta-analysis of Randomized Controlled Trials. Journal
of Cancer. 2015;6(9):883-92.
19. Izawa N, Onozawa Y, Hikosaka T, Hamauchi S, Tsushima T, Todaka A, et
al. Efficacy and feasibility of docetaxel, cisplatin, and 5-fluorouracil
induction chemotherapy for locally advanced head and neck squamous cell
carcinoma classified as clinical nodal stage N2c, N3, or N2b with
supraclavicular lymph node metastases. International journal of clinical
oncology. 2015;20(3):455-62.
20. Ghi MG, Paccagnella A, Ferrari D, Foa P, Alterio D, Codecà C, et al.
Induction TPF followed by concomitant treatment versus concomitant
treatment alone in locally advanced head and neck cancer. A phase II-III
trial. Annals of oncology : official journal of the European Society for
Medical Oncology. 2017;28(9):2206-12.
21. Dagan O, Moore A, Nachalon Y, Alkan U, Biadsee A, Shochat I, et al.
Induction chemotherapy for locally advanced laryngeal and hypopharyngeal
cancer: Single institution experience. Head & neck.
2020;42(11):3118-24.
22. Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin
M, et al. Cisplatin, fluorouracil, and docetaxel in unresectable head
and neck cancer. The New England journal of medicine.
2007;357(17):1695-704.
23. Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E,
Gorbounova V, et al. Cisplatin and fluorouracil alone or with docetaxel
in head and neck cancer. The New England journal of medicine.
2007;357(17):1705-15.
24. Dogan V, Rieckmann T, Münscher A, Busch CJ. Current studies of
immunotherapy in head and neck cancer. Clinical otolaryngology :
official journal of ENT-UK ; official journal of Netherlands Society for
Oto-Rhino-Laryngology & Cervico-Facial Surgery. 2018;43(1):13-21.